about
Parathyroid hormone pulsatility: physiological and clinical aspectsThe association between metabolic syndrome and bone mineral density: a meta-analysis.Association of polymorphisms in the leptin and leptin receptor genes with inflammatory mediators in patients with osteoporosis.Osteoporosis in patients taking selective serotonin reuptake inhibitors: a focus on fracture outcome.Use of parathyroid hormone in hypoparathyroidism.Bisphosphonate-Related Osteonecrosis of the Jaws and Its Array of Manifestations.Correlation of serum testosterone with insulin resistance in elderly male type 2 diabetes mellitus patients with osteoporosis.Selective Estrogen Receptor Modulators Suppress Hif1α Protein Accumulation in Mouse Osteoclasts.Treatment options for postmenopausal osteoporosis.Multiple myeloma in the marrow: pathogenesis and treatments.Mini-review: new therapeutic options in hypoparathyroidism.Health technology assessment in osteoporosis.Effects of Statins on Bone Mineral Density and Fracture Risk: A PRISMA-compliant Systematic Review and Meta-AnalysisPlasminogen activator inhibitor-1 is involved in streptozotocin-induced bone loss in female mice.Avenanthramides Prevent Osteoblast and Osteocyte Apoptosis and Induce Osteoclast Apoptosis in Vitro in an Nrf2-Independent Manner.Role of T cells in the modulation of PTH action: physiological and clinical significanceStability of mRNA influences osteoporotic bone mass via CNOT3.Skeletal and extraskeletal actions of denosumab.Pharmacogenomics of osteoporosis: a pathway approach.New advances in imaging osteoporosis and its complications.Osteoporosis in chronic inflammatory disease: the role of malnutrition.Osteoporosis in men: recent progress.Glucocorticoids and the regulation of growth hormone secretion.Should we abandon statins in the prevention of bone fractures?Muscle-bone and fat-bone interactions in regulating bone mass: do PTH and PTHrP play any role?Utility of the trabecular bone score (TBS) in secondary osteoporosis.Role of bone mineral density in predicting morphometric vertebral fractures in patients with HIV infection.Relationship of lean body mass with bone mass and bone mineral density in the general Korean population.Association of nonalcoholic fatty liver disease with low bone mass in postmenopausal women.Interactions between mesenchymal stem cells, adipocytes, and osteoblasts in a 3D tri-culture model of hyperglycemic conditions in the bone marrow microenvironment.Short Anabolic Peptides for Bone Growth.Acromegalic osteopathy.Incidence of morphometric vertebral fractures in adult patients with growth hormone deficiency.An increased risk for fractures: another cause of frailty in HIV-infected subjects.The serum undercarboxylated osteocalcin level and the diet of a Japanese population: results from the Kyushu and Okinawa Population Study (KOPS).Is there a role for combination therapy for osteoporosis?Dietary tryptophan manipulation reveals a central role for serotonin in the anabolic response of appendicular skeleton to physical activity in rats.Genetic association study of WNT10B polymorphisms with BMD and adiposity parameters in Danish and Belgian males.Lycium barbarum polysaccharide arbitrates palmitate-induced apoptosis in MC3T3‑E1 cells through decreasing the activation of ERS‑mediated apoptosis pathway.Altered gene expression involved in insulin signaling pathway in type II diabetic osteoporosis rats model.
P2860
Q26798180-B4F7414F-00E0-4946-8AD2-87A50E919112Q34252441-1C344090-A11C-4075-81B9-BF7A6A033278Q34330975-D0081D6F-EA4E-45E1-81ED-078D36AAD4E6Q34432269-02C9C134-67AF-4024-B70C-0E03D6D320A6Q35043115-F5384DDA-19D5-45B6-845A-C3FCA04E39FCQ35880807-17D1B800-5190-4C6D-8D6B-156ECDF0FB08Q36082243-94FD70DE-4E9E-4EF6-8D4B-EEC7039E69D6Q36179411-A48CB1C4-178E-489A-9B19-37D205B94363Q36202821-F6FF32A5-3810-4EB9-A09E-6984EA042119Q36725401-41FBEFE0-4981-4551-86E6-BF11B435C9B3Q36949203-FA711027-B672-4919-B2E0-5DB96DF2185DQ36965411-B5C5E5AD-25F4-437E-BC42-3186DCADC4DDQ36988655-166F823E-8FE3-4C10-B4BD-095A414EA851Q37110567-A1D54964-2A4C-4AA2-8CD3-174E6CFE12B5Q37133071-CAFE8C16-1762-4F5C-B3B5-A1200E0D0600Q37274471-08F4E19F-5E1D-4335-923E-F6ED6C894A9EQ37599907-91EAFF43-29D9-4226-BC88-D2565A4317BEQ38009712-DAE8C87A-9B08-40BA-AE76-4E3D37108002Q38010749-39116A9C-6BB1-4C1F-A1BF-340DAB77D2F2Q38012361-A2CB518D-9AA5-441D-BA46-1D7FC24BE66EQ38051265-82E4C467-8515-4008-9311-F0F061277A32Q38077109-8A154191-4C4A-4CFF-81D7-831ABE6E8B70Q38079133-82810A4C-53F2-40BD-A4C1-86ED787BD7F7Q38092753-0001CDE9-4A95-4566-B55B-8B9998FD2A6AQ38209810-B5CF1753-FAEB-4259-9AEF-76CA2A456DB8Q38213973-02149278-9729-4860-B7E4-16F2BE8E85F1Q38435884-59F4568A-7656-4596-A7A4-3B8844DDD681Q38442460-40BD13F5-CD53-480A-8ECE-9356D146A067Q38464557-2288774D-32DD-4FAC-9BC8-67B3FB2C9BEAQ38496332-39764C9A-E3B3-4339-BA7D-DB417C559DD5Q38864194-359CECFA-1FD6-4546-B0FC-C1FF328128A4Q38973343-BA50B63A-AE8A-43DE-B6DC-74154EF6232DQ40470381-C6B9EC6E-F4F0-4C91-BF7B-69567A806B01Q44807343-885B20A3-D5A6-4CF7-B7F1-76D4AB0C69FCQ45694792-4E9D06D7-B238-42BC-93B3-9B6C48EDC94EQ45903584-82DF7486-A9A1-434F-93D0-7B6097CF71C8Q46566420-FE70801C-8B85-4A9A-B4C7-E6166F3D71F4Q46902624-50E6AE74-B0B6-44C1-B5B2-DC5274BD104EQ47328893-36165722-E883-40CC-81B0-9154B3CD8253Q47356825-FC9C1127-8233-43AC-BDE0-A2AE65600C8B
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
New understanding and treatments for osteoporosis.
@en
New understanding and treatments for osteoporosis.
@nl
type
label
New understanding and treatments for osteoporosis.
@en
New understanding and treatments for osteoporosis.
@nl
prefLabel
New understanding and treatments for osteoporosis.
@en
New understanding and treatments for osteoporosis.
@nl
P2093
P2860
P1433
P1476
New understanding and treatments for osteoporosis.
@en
P2093
A Giustina
G Mazziotti
J Bilezikian
P2860
P2888
P356
10.1007/S12020-011-9570-2
P577
2012-02-01T00:00:00Z